PATENT CLAIM ANALYSIS

Application Number: 15917106
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "169000"]

Abstract:
The present disclosure is directed to methods of treating cancer comprising administering dihydrotestosterone, a dihydrotestosterone derivative, a dihydrotestosterone promoter, or a combination thereof to a patient in need of treatment.

Claim (Index 2):
The method of  claim 1 , wherein the amount of the dihydrotestosterone, a dihydrotestosterone derivative, a dihydrotestosterone promoter, or a combination thereof is sufficient to produce calcification of at least a portion of the cancer.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 90.0
- Lexical Diversity: 1.36
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13371076', '15158679', '15158712', '15351966', '14750877']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.795248124666259
- 35 USC 102 Novelty (BERT): 0.5491650888057876
- Combined Prediction Score: 0.7706398210802119
- Mean Citation Score: 400.203866
- Max Citation Score: 407.39423
- Similarity Product: 250.0557086382813

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test